Science Current Events | Science News | Brightsurf.com
 

Trial Seeks 'Genetic Fingerprint' for Predicting Drug Effectiveness

October 04, 2007
Cincinnati-University of Cincinnati (UC) physician-scientists believe identifying a genetic "fingerprint" could help predict which specific therapies will be most effective for patients with gastric cancer.

Syed Ahmad, MD, is leading a national, phase-2 trial to test the effectiveness of combined chemotherapy and radiation therapy given to patients with gastric cancer before surgery. His team will also collect biological samples in an attempt to obtain genetic data that could be used to formulate targeted therapies.

Previous studies have established that either chemotherapy or radiation therapy after surgery can improve patient survival compared with surgery alone. Overall survival rates, however, remain low-with 20 to 30 percent of American patients surviving more than five years after treatment.

"Everyone agrees that without surgery, gastric cancer in not curable, and numerous studies have shown a benefit to follow-­up therapy with either chemotherapy or radiation therapy," says Ahmad, assistant professor of surgery at UC and principal investigator of the trial.

"The problem is you can't give both radiation therapy and chemotherapy after surgery-it's too toxic and patients can't tolerate it," he says. "But you can give it before surgery when patients are healthiest."

This trial addresses what Ahmad calls the "future of cancer therapy": targeted drug regimens, based on the characteristics of a patient's specific tumor.

His goal is to identify a genetic "fingerprint" that could help predict whether patients will respond to therapy, and then identify drugs to address the specific molecular characteristics of that patient's tumor.

"Right now treatment is based on the assumption that site-based cancers are all the same, so every patient who has stage-3 gastric cancer will get the same chemotherapy drugs," Ahmad explains. "But the reality is that every cancer has a different expression of hormones, growth factors and genetic factors that must be addressed individually."

The UC-led national team is looking for about 70 patients across the United States with up to stage-3 gastric cancer to participate in the trial.

Prior to surgery, all study participants will have a biopsy to set baseline standards for genetic testing to determine which patients have a complete response to the multi-treatment therapy. Participants will receive daily doses of the platinum-containing drug oxaliplatin (ox-AL'-ih-plah-tin, marketed as Eloxatin) for six to eight weeks.

Approved by the Food and Drug Administration, oxaliplatin is currently used to treat advanced colorectal cancer. Studies have shown the drug has fewer toxicity complications compared with other therapies.

After six weeks of chemotherapy, the patient will get five consecutive days of three-dimensional, external-beam radiation therapy. Patients will be reevaluated two to three weeks after radiation to determine if they are eligible for surgery. Those who are suitable will have another tissue biopsy after surgery.

Researchers will compare pre- and post-surgery tissue samples to obtain the genetic data necessary to establish associations between molecular markers and drug resistance, with the goal of reducing toxicity associated with chemotherapeutic agents and improving patient survival.

University of Cincinnati


Related Chemotherapy Current Events and Chemotherapy News Articles


Cancer during pregnancy: Chemotherapy and radiotherapy are safe for babies, studies show
Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown.

Docetaxel or pemetrexed with cisplatin achieve comparable outcomes in non-squamous Lu Ca
The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival, although docetaxel was associated with more frequent adverse events.

Customising chemotherapy in Lu Ca: New Ph II data reported in 2 LB studies
Measuring the expression levels of an enzyme involved in DNA synthesis can help predict the response of lung cancers to certain treatments, a Korean study has shown at the ESMO 2014 Congress in Madrid.

Evolutionary biology: It's not just for textbooks anymore
Solving global challenges in food security, emerging diseases and biodiversity loss requires evolutionary thinking, argues a new study published online in Science Express that was co-authored by Bruce Tabashnik of the University of Arizona College of Agriculture and Life Sciences.

IMPRESS trial data on continuing tyrosine kinase inhibitor therapy after resistance development in lung cancer reported
Patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in addition to chemotherapy, a phase III trial presented at the ESMO 2014 Congress has shown.

Pertuzumab adds 16 months survival benefit to trastuzumab and chemo treatment for HER2-positive breast cancer
Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal.

Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.

Nivolumab shows signs of superior response rate compared to standard chemo in advanced melanoma
The monoclonal antibody nivolumab achieves superior response rates and a longer duration of response than standard chemotherapy in patients whose melanoma has progressed after treatment with ipilimumab, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

Studies report new findings on treatment options for mesothelioma
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.

Protein 'map' could lead to potent new cancer drugs
Imperial chemists have gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped.
More Chemotherapy Current Events and Chemotherapy News Articles

Chemo: Secrets to Thriving: From someone who's been there.

Chemo: Secrets to Thriving: From someone who's been there.
by Roxanne Brown (Author), Barbara Mastej (Contributor), John S. Link M.D. (Contributor)


The thought of chemotherapy can be overwhelming, but getting through it doesn’t have to be. Chemo: Secrets to Thriving helps lighten the load. In chronological order, step-by- step, you learn what might occur, why it happens, what you can do (with your doc’s approval), and who to contact for help. Chemo: Secrets to Thriving will be your friend, companion, and guide, giving you the resources to handle possible side effects and better manage your life during chemotherapy. Once you know the secrets in this book you may find yourself still able to enjoy life—and even thrive—while going through chemotherapy. Our endorsements aren’t from the usual celebrities, but from our celebrities: medical teams, fellow chemo travelers, and the people and places that support them.

The Chemotherapy Survival Guide: Everything You Need to Know to Get Through Treatment

The Chemotherapy Survival Guide: Everything You Need to Know to Get Through Treatment
by Judith McKay (Author), Tammy Schacher RN OCN MSN (Author)


When you're facing cancer treatment, it's easy to feel overwhelmed and alone. Between the hospital or clinic environment and the medical terminology used by doctors and health care professionals, you may feel as though you've entered a foreign country.Written by two experienced oncology nurses, this compassionate and comprehensive guide explains in plain English everything you need to know about your treatment, including what you can expect at each stage of chemotherapy and what you can do to prevent or minimize side effects. Packed with practical suggestions, nutritional advice, relaxation skills, and other techniques to help strengthen your body and calm your mind, The Chemotherapy Survival Guide is a must-have resource for anyone navigating this difficult...

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice
by Martha Polovich (Author), MiKeala Olsen (Author), Kris Lefebvre (Author)


Order your copy of the fourth edition of the best-selling resource used by more than 101,000 healthcare professionals since 2009 and keep up-to-date on the latest chemotherapy, biotherapy, and targeted agents. This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your specialty. You'll find that this latest edition incorporates a number of significant changes. To help you find the content and information that you need quickly and easily, the text has been reorganized and is now divided into 11 chapters ranging from an overview of cancer and cancer treatment and principles of antineoplastic therapy to post-treatment care and competencies in chemotherapy administration....

The Chemotherapy Diet: 5 Steps to Staying Healthy During Cancer Treatment

The Chemotherapy Diet: 5 Steps to Staying Healthy During Cancer Treatment
by Mike Herbert ND (Author), Joseph Dispenza (Contributor)


During cancer treatment, it is vitally important to stay healthy. The best way of doing that is to work with the body's own natural healing abilities. And that means, in the first place to eat right.

The Chemotherapy Diet is a practical guide to feeling good during chemo... and beyond with 100+ simple recipes, menu planning guide, and more, presented in a simple 5-step program:

Change your thinking and develop an attitude focused on healing. Detoxify with therapeutic baths to promote healing from the inside out. Eat the best foods to create a healing chemistry in your body. Supplement your diet to support the healing momentum. Exercise and rest to speed the healing process.

Physicians' Cancer Chemotherapy Drug Manual 2014 (Jones and Bartlett Series in Oncology(Physician's Cancer Chemotherapy Drug Manual))

Physicians' Cancer Chemotherapy Drug Manual 2014 (Jones and Bartlett Series in Oncology(Physician's Cancer Chemotherapy Drug Manual))
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2014, the Physicians’ Cancer Chemotherapy Drug Manual 2014 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers. Special features: • Revised to reflect rapid advances in the field • A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of the agents. • Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages....

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice
by Julie M. Whitford (Editor), Mikaela M. Olsen (Editor), Martha Polovich (Editor)


Edited by Martha Polovich, Julie M. Whitford, and MiKaela Olsen, this new edition has been revised and updated to reflect the current procedures and practices in your specialty. Featured are sections detailing principles of antineoplastic therapy, cancer therapy goals and response, fundamentals of administration, pre-treatment, treatment and post-treatment care, side effects of cancer therapy, immediate complications of cytotoxic therapy, and more. Also included are treatment schedules, including dose category and determination, as well as nursing and chemotherapy flow charts, information on safe management of chemotherapy in the home, clinical practicum and evaluations, and much, much more.

Chemotherapy and Radiation For Dummies

Chemotherapy and Radiation For Dummies
by Alan P. Lyss MD (Author), Humberto Fagundes MD (Author), Patricia Corrigan (Author)


An informative, compassionate guide for cancer patients and their loved onesEach year, more than 1 million people get treated for cancer, and most of these will undergo chemotherapy, radiation therapy, or both. This reassuring, optimistic guide helps people get a handle on treatment options and explains in plain English how chemotherapy and radiation therapy really work. It offers detailed advice on how to alleviate and cope with side effects-which range from hair loss to nausea to anemia-and describes how good nutrition, meditation, support groups, and other techniques and resources can help in the recovery process.

Pocket Guide To Chemotherapy Protocols

Pocket Guide To Chemotherapy Protocols
by Edward Chu (Author)


Newly updated for 2012, the Pocket Guide to Chemotherapy Protocols, Seventh Edition, is a spiral-bound quick-reference guide arranged alphabetically by cancer type. This handy, practical pocket guide contains combination, as well as selected single-agent regimens for solid tumor and hematologic malignancies. In each case, the regimens selected are based on published literature and are used in clinical practice in the medical oncology community. The Seventh Edition of the bestselling pocket guide is completely revised and updated and continues the success of previous editions by offering cancer care professionals complete, authoritative information in a convenient format. Pocket Guide to Chemotherapy Protocols is a must-have quick reference guide for physicians, nurses, and other health...

Healthy Eating During Chemotherapy

Healthy Eating During Chemotherapy
by Jose van Mil (Author), Christina Mackenzie-Archer (Author)


People undergoing chemotherapy often experience changes in appetite and taste. Similar problems frequently arise during radiotherapy, Another common side effect is a sore mouth, making it painful to eat. At the same time, it is vital for their recovery that patients keep their body weight up. This unique cookbook is the first of its kind, offering nutritional advice and delicious recipes to help cancer patients keep on enjoying food while fighting to get better. Devised by a chef and based on medical research, the first section of the book discusses which foods are good to eat and which are not. The second part of the book contains over 160 recipes that have been created to soothe the palate. With chapter titles like Smooth, Crispy, and Soft with a Bite, the recipes focus on the...

Handbook of Cancer Chemotherapy (Lippincott Williams & Wilkins Handbook Series)

Handbook of Cancer Chemotherapy (Lippincott Williams & Wilkins Handbook Series)
by Roland T. Skeel (Author), Samir N. Khlief (Author)


Skeel's Handbook of Cancer Chemotherapy combines in one place the most current rationale and specific details necessary to administer chemotherapy for most adult cancers. The handbook is a practical, diseased-focused pocket reference that emphasizes the best current medical practice as it relates to the delivery of chemotherapeutic drugs. By focusing on specific plans for treatment, the book is an invaluable resource for the daily care of cancer patients.

© 2014 BrightSurf.com